GAMMA Investing’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$124K Buy
4,819
+592
+14% +$13.7K ﹤0.01% 1648
2026
Q1
$86.9K Sell
4,227
-87
-2% -$1.96K ﹤0.01% 1788
2025
Q4
$102K Buy
4,314
+2,869
+199% +$69.8K 0.01% 1563
2025
Q3
$36K Sell
1,445
-1,490
-51% -$32.1K ﹤0.01% 2202
2025
Q2
$67.5K Buy
2,935
+69
+2% +$1.6K ﹤0.01% 1715
2025
Q1
$64.3K Buy
2,866
+1,521
+113% +$35.3K ﹤0.01% 1611
2024
Q4
$26.3K Sell
1,345
-356
-21% -$7.05K ﹤0.01% 2116
2024
Q3
$31K Buy
1,701
+845
+99% +$16.1K ﹤0.01% 1828
2024
Q2
$14.9K Sell
856
-36
-4% -$638 ﹤0.01% 2041
2024
Q1
$17.5K Buy
892
+189
+27% +$3.99K ﹤0.01% 1736
2023
Q4
$14.2K Buy
+703
New +$15.7K ﹤0.01% 1708

Other funds holding PRVA

GAMMA Investing's PRVA Position: Q2 2026 in Review

GAMMA Investing increased its Privia Health (PRVA) stake by 14% in Q2 2026, buying an estimated $13.7K and bringing the position to 4,819 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #1648.

GAMMA Investing first reported a position in PRVA in Q4 2023 and has held it in 11 quarters since. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • GAMMA Investing held 4,819 shares of Privia Health worth $124K as of Q2 2026.
  • GAMMA Investing bought 592 Privia Health shares in Q2 2026, an estimated $13.7K.
  • Privia Health made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #1648 holding.
  • GAMMA Investing first reported a position in Privia Health in Q4 2023 and has held it in 11 quarters since.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.